Showing results (21-30 of 224) with videos related to
Sort By:
Pageof 23
Current Opinion in Hematology|July 16, 2013
Treatment with novel oral anticoagulants: indications, efficacy and risksShari Ghanny, Mark CrowtherCritical Care (London, England)|August 2, 2006
Measuring the anticoagulant effect of low molecular weight heparins in the critically illMark Crowther, Wendy LimCritical Care Medicine|January 20, 2010
Antiphospholipid antibodies in critical illnessFrancesco Dentali, Mark CrowtherMusculoskeletal Surgery|January 29, 2021
Olecranon fractures in the elderly during the COVID-19 pandemic: Is non-operative treatment reasonable? Review of the current evidenceAmir Abdelmalek, Mark CrowtherClinical Advances in Hematology & Oncology : H&O|September 21, 2005
New anticoagulants: an updateMark Crowther, Jeffrey I WeitzCurrent Rheumatology Reports|April 29, 2010
Intensity of warfarin coagulation in the antiphospholipid syndromeMark Crowther, Mark A CrowtherArteriosclerosis, Thrombosis, and Vascular Biology|June 20, 2015
Antidotes for novel oral anticoagulants: current status and future potentialMark Crowther, Mark A CrowtherHematology/Oncology Clinics of North America|July 28, 2010
Antiphospholipid syndrome: a challenging hypercoagulable state with systemic manifestationsMarco P Donadini, Mark CrowtherThrombosis Research|September 24, 2014
Rofecoxib does not appear to increase the risk of venous thromboembolism: a systematic review of the literatureJennifer Goy, Jeremy Paikin, Mark CrowtherPageof 23